Linked Data API

Show Search Form

Search Results

1538289
registered interest false more like this
date less than 2022-11-01more like thismore than 2022-11-01
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many people are prescribed cannabis-based medicines via private healthcare services in the UK. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 76000 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-11-08more like thismore than 2022-11-08
answer text <p>The information requested is not held centrally.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2022-11-08T17:16:44.407Zmore like thismore than 2022-11-08T17:16:44.407Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1247151
registered interest false more like this
date less than 2020-10-30more like thismore than 2020-10-30
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department (a) is taking to improve access to medicinal cannabis for people living with multiple sclerosis and (b) if he will publish a Government strategy for improving access to medicinal cannabis. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 109474 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-11-17more like thismore than 2020-11-17
answer text <p>Two prescription medicines - Sativex – for the treatment of spasticity in Multiple Sclerosis patients, and Epidyolex – for the treatment of seizures associated with two rare forms of epilepsy, have been made available for prescribing on the National Health Service, where clinically appropriate. This follows clear demonstrated evidence of their safety, and clinical and cost effectiveness.</p><p>We continue to work hard with the health system, industry and researchers to improve the evidence base for other cannabis-based medicines, and to implement the recommendations of NHS England and NHS Improvement’s review on barriers to accessing unlicensed cannabis based medicinal products. This includes the design of clinical trials and the establishment of a national patient registry.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2020-11-17T13:43:29.213Zmore like thismore than 2020-11-17T13:43:29.213Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1247153
registered interest false more like this
date less than 2020-10-30more like thismore than 2020-10-30
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many prescriptions for unlicensed cannabis-based medicines the NHS issued in 2020. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 109476 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-11-17more like thismore than 2020-11-17
answer text <p>There have been 1,700 items for Sativex prescribed on an NHS prescription, dispensed in the community in England and submitted to the NHS Business Services Authority for reimbursement for the period November 2019 to August 2020, the latest data available. The following table shows the number of items by month.</p><table><tbody><tr><td><p>Month</p></td><td><p>Items</p></td></tr><tr><td><p>November 2019</p></td><td><p>172</p></td></tr><tr><td><p>December 2019</p></td><td><p>177</p></td></tr><tr><td><p>January 2020</p></td><td><p>175</p></td></tr><tr><td><p>February 2020</p></td><td><p>160</p></td></tr><tr><td><p>March 2020</p></td><td><p>177</p></td></tr><tr><td><p>April 2020</p></td><td><p>187</p></td></tr><tr><td><p>May 2020</p></td><td><p>154</p></td></tr><tr><td><p>June 2020</p></td><td><p>167</p></td></tr><tr><td><p>July 2020</p></td><td><p>178</p></td></tr><tr><td><p>August 2020</p></td><td><p>153</p></td></tr></tbody></table><p><br>The NHS Business Service Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis-based products dispensed in the community in England. This information is being withheld in accordance with the General Data Protection Regulation, due to the number of items attributed to less than five patients and potential for patient identifiable information to be published.</p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 109475 more like this
question first answered
less than 2020-11-17T14:04:54.27Zmore like thismore than 2020-11-17T14:04:54.27Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1229118
registered interest false more like this
date less than 2020-08-28more like thismore than 2020-08-28
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 June 2020 to Question 57346 on Cannabis: Medical Treatments, what progress the Government has made on implementing a patient registry to monitor outcomes among medical cannabis patients. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 82094 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-09-14more like thismore than 2020-09-14
answer text <p>The patient registry for cannabis-based products for medicinal use is currently being developed by NHS England and NHS Improvement with input from specialist clinicians and other advisory bodies. The purpose of this registry is to collect a uniform data set for patients prescribed these products, including patient outcomes. NHS England and NHS Improvement intends to pilot the registry this autumn, to enable operational use as soon as practicable.</p><p> </p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2020-09-14T18:28:31.767Zmore like thismore than 2020-09-14T18:28:31.767Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1229119
registered interest false more like this
date less than 2020-08-28more like thismore than 2020-08-28
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many unlicensed cannabis-based products have been prescribed on an NHS prescription, dispensed in the community in England and submitted to the NHS Business Services Authority for reimbursement in each month from November 2018 to August 2020. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 82095 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-09-14more like thismore than 2020-09-14
answer text <p>The NHS Business Services Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis-based products dispensed in community pharmacy in England. This information is being withheld in accordance with the General Data Protection Regulation, due to the number of items attributed to less than five patients and potential for patient identifiable information to be published.</p><p>313 private prescription items for unlicensed cannabis-based products were prescribed and dispensed in community pharmacy in England (November 2018 – February 2020). During the COVID-19 outbreak, the NHS Business Services Authority temporarily suspended the processing of private prescriptions of this nature, so data between March 2020 and August 2020 is currently unavailable.</p><p> </p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 82096 more like this
question first answered
less than 2020-09-14T19:12:55.627Zmore like thismore than 2020-09-14T19:12:55.627Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1229120
registered interest false more like this
date less than 2020-08-28more like thismore than 2020-08-28
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many private prescription items for unlicensed cannabis-based medicines have been prescribed and submitted to the NHS Business Services Authority in each month from November 2018 to August 2020. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 82096 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-09-14more like thismore than 2020-09-14
answer text <p>The NHS Business Services Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis-based products dispensed in community pharmacy in England. This information is being withheld in accordance with the General Data Protection Regulation, due to the number of items attributed to less than five patients and potential for patient identifiable information to be published.</p><p>313 private prescription items for unlicensed cannabis-based products were prescribed and dispensed in community pharmacy in England (November 2018 – February 2020). During the COVID-19 outbreak, the NHS Business Services Authority temporarily suspended the processing of private prescriptions of this nature, so data between March 2020 and August 2020 is currently unavailable.</p><p> </p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 82095 more like this
question first answered
less than 2020-09-14T19:12:55.677Zmore like thismore than 2020-09-14T19:12:55.677Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1189310
registered interest false more like this
date less than 2020-04-22more like thismore than 2020-04-22
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many prescriptions for cannabis-based products for medicinal use have been issued on the NHS since the rescheduling of those products. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 39000 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-05-04more like thismore than 2020-05-04
answer text <p>There have been 3,546 items for licensed and unlicensed cannabis-based medicines prescribed on a National Health Service prescription, dispensed in the community in England and submitted to the NHS Business Services Authority for reimbursement for the period November 2018 to February 2020 (latest data available).</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2020-05-04T13:01:12.42Zmore like thismore than 2020-05-04T13:01:12.42Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1189313
registered interest false more like this
date less than 2020-04-22more like thismore than 2020-04-22
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the guidance entitled, The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use in humans specials, published by the Medicines and Healthcare Products Regulatory Agency in March 2020, what discussions officials in his Department have had with officials in the Home Office on ensuring that import licences for cannabis-based products for medicinal use are granted without delay; and if he will make a statement. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 39003 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-05-04more like thismore than 2020-05-04
answer text <p>The Department continues to work closely with the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) to maintain the supply of unlicensed cannabis-based products for medicinal use (CBPMs) to ensure that patients with prescriptions from specialist doctors can access their medicine. The Home Office and the MHRA treat all import requests for CBPMs as emergency supplies, and on receipt of the correct documentation, applicants receive decisions within a few working days.</p><p>The Government made changes to import policy in March 2020 to enable pharmaceutical wholesalers to apply to import CBPMs in anticipation of prescriptions, instead of only applying to import the quantity specified on a prescription. We are continuing to work with industry to ensure supply remains uninterrupted during the COVID-19 outbreak.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2020-05-04T13:04:04.123Zmore like thismore than 2020-05-04T13:04:04.123Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1173615
registered interest false more like this
date less than 2020-01-27more like thismore than 2020-01-27
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what discussions officials of his Department has had with officials of the Home Office to ensure there are no undue delays in granting import licences for cannabis-based products for medicinal use; and if he will make a statement. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 8359 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-04more like thismore than 2020-02-04
answer text <p>We are aware that some wholesalers and pharmacies have reported challenges in importing a range of unlicensed cannabis-based products for medicinal use. It is clear that for some products, long lead times and delays in receiving export licences from the authorities in the country of manufacture, have led to delays in the supply against prescriptions and pose a potential risk to patients receiving their medicines on time.</p><p>The Department, the Medicines and Healthcare products Regulatory Agency (MHRA), the Home Office, NHS England and NHS Improvement are in the process of agreeing what action can be taken to help alleviate these delays, including exploring mechanisms to allow licensed wholesalers to hold a small reserve stock linked to an evidenced demand by specialist prescribers; and ensuring that the United Kingdom meets its obligations under the Single Convention on Narcotic Drugs. Any changes will be reflected in the guidance published by the MHRA.</p><p>In the meantime, the Home Office and the MHRA are treating all import requests for cannabis-based products for medicinal use as emergency supplies and on receipt of the correct documentation, applicants can expect a decision within a few working days.</p><p>No meetings have taken place with representatives of patient groups concerning the reported delays to imports of cannabis-base products for medicinal use. Officials did meet with patient groups in the development of this policy when the previous Government rescheduled cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001.</p><p> </p><p> </p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN
8360 more like this
8361 more like this
question first answered
less than 2020-02-04T17:26:56.3Zmore like thismore than 2020-02-04T17:26:56.3Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1173616
registered interest false more like this
date less than 2020-01-27more like thismore than 2020-01-27
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what meetings (a) he, (b) Special Advisers to ministers of his Department, and (c) officials of his Department have attended with representatives of patient groups on the import of cannabis-based products for medicinal use since 1 January 2018. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 8360 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-04more like thismore than 2020-02-04
answer text <p>We are aware that some wholesalers and pharmacies have reported challenges in importing a range of unlicensed cannabis-based products for medicinal use. It is clear that for some products, long lead times and delays in receiving export licences from the authorities in the country of manufacture, have led to delays in the supply against prescriptions and pose a potential risk to patients receiving their medicines on time.</p><p>The Department, the Medicines and Healthcare products Regulatory Agency (MHRA), the Home Office, NHS England and NHS Improvement are in the process of agreeing what action can be taken to help alleviate these delays, including exploring mechanisms to allow licensed wholesalers to hold a small reserve stock linked to an evidenced demand by specialist prescribers; and ensuring that the United Kingdom meets its obligations under the Single Convention on Narcotic Drugs. Any changes will be reflected in the guidance published by the MHRA.</p><p>In the meantime, the Home Office and the MHRA are treating all import requests for cannabis-based products for medicinal use as emergency supplies and on receipt of the correct documentation, applicants can expect a decision within a few working days.</p><p>No meetings have taken place with representatives of patient groups concerning the reported delays to imports of cannabis-base products for medicinal use. Officials did meet with patient groups in the development of this policy when the previous Government rescheduled cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001.</p><p> </p><p> </p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN
8359 more like this
8361 more like this
question first answered
less than 2020-02-04T17:26:56.347Zmore like thismore than 2020-02-04T17:26:56.347Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter